Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
CHINOOK THERAPEUTICS, INC. (KDNY)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/11/2023 |
4
| Thomas Dolca (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 13,300 shares
@ $0 Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
08/11/2023 |
4
| Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 160,000 options to buy
@ $21.82, valued at
$3.5M
Disposed/sold 40,000 restricted stock units
@ $0 |
|
08/11/2023 |
4
| Krishnan Mahesh (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 1,275 shares
@ $0 Disposed/sold 26,600 options to buy
@ $16.74, valued at
$445.3k
Disposed/sold 4,401 restricted stock units
@ $0 |
|
08/11/2023 |
4
| King Andrew James (Chief Scientific Officer) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 19,157 shares
@ $0 Disposed/sold 43,047 options to buy
@ $0.35, valued at
$15.1k
Disposed/sold 73,047 options to buy
@ $0.42, valued at
$30.7k
Disposed/sold 89,545 options to buy
@ $14.77, valued at
$1.3M
Disposed/sold 60,000 options to buy
@ $15.14, valued at
$908.4k
Disposed/sold 21,500 options to buy
@ $17.59, valued at
$378.2k
Disposed/sold 100,000 options to buy
@ $12.9, valued at
$1.3M
Disposed/sold 104,000 options to buy
@ $25.27, valued at
$2.6M
Disposed/sold 10,152 restricted stock units
@ $0 Disposed/sold 6,802 restricted stock units
@ $0 Disposed/sold 16,667 restricted stock units
@ $0 |
|
08/11/2023 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 3,300 shares
@ $0 Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
08/11/2023 |
4
| Greenman William Mariner (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 23,643 shares
@ $0 Disposed/sold 3,600 options to buy
@ $5, valued at
$18k
Disposed/sold 8,000 options to buy
@ $85, valued at
$680k
Disposed/sold 2,600 options to buy
@ $62.1, valued at
$161.5k
Disposed/sold 2,600 options to buy
@ $52.75, valued at
$137.2k
Disposed/sold 4,000 options to buy
@ $33, valued at
$132k
Disposed/sold 6,000 options to buy
@ $16.45, valued at
$98.7k
Disposed/sold 6,000 options to buy
@ $15, valued at
$90k
Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
08/11/2023 |
4
| Frohlich Tom (COO) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 150,777 shares
@ $0 Disposed/sold 43,847 options to buy
@ $0.42, valued at
$18.4k
Disposed/sold 119,793 options to buy
@ $14.77, valued at
$1.8M
Disposed/sold 60,000 options to buy
@ $15.14, valued at
$908.4k
Disposed/sold 30,000 options to buy
@ $17.59, valued at
$527.7k
Disposed/sold 100,000 options to buy
@ $12.9, valued at
$1.3M
Disposed/sold 84,000 options to buy
@ $25.27, valued at
$2.1M
Disposed/sold 13,581 restricted stock units
@ $0 Disposed/sold 6,801 restricted stock units
@ $0 Disposed/sold 16,667 restricted stock units
@ $0 Disposed/sold 21,000 restricted stock units
@ $0 |
|
08/11/2023 |
4
| DOBMEIER ERIC (President, CEO) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 301,138 shares
@ $0 Disposed/sold 353,358 options to buy
@ $0.35, valued at
$123.7k
Disposed/sold 313,555 options to buy
@ $0.42, valued at
$131.7k
Disposed/sold 271,647 options to buy
@ $14.77, valued at
$4M
Disposed/sold 178,600 options to buy
@ $15.14, valued at
$2.7M
Disposed/sold 300,000 options to buy
@ $12.9, valued at
$3.9M
Disposed/sold 255,150 options to buy
@ $25.27, valued at
$6.4M
Disposed/sold 30,797 restricted stock units
@ $0 Disposed/sold 20,248 restricted stock units
@ $0 Disposed/sold 50,001 restricted stock units
@ $0 Disposed/sold 64,050 restricted stock units
@ $0 |
|
08/11/2023 |
4
| Jerel Davis (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 447,013 shares
@ $0 Disposed/sold 2,105,107 shares
@ $0 Disposed/sold 719,104 shares
@ $0 Disposed/sold 210,996 shares
@ $0 Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
08/11/2023 |
4
| BJERKHOLT ERIC (CFO) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 39,371 shares
@ $0 Disposed/sold 144,787 options to buy
@ $13.98, valued at
$2M
Disposed/sold 21,501 options to buy
@ $15.14, valued at
$325.5k
Disposed/sold 88,000 options to buy
@ $12.9, valued at
$1.1M
Disposed/sold 84,000 options to buy
@ $25.27, valued at
$2.1M
Disposed/sold 16,415 restricted stock units
@ $0 Disposed/sold 2,435 restricted stock units
@ $0 Disposed/sold 14,667 restricted stock units
@ $0 Disposed/sold 21,000 restricted stock units
@ $0 Disposed/sold 8,400 restricted stock units
@ $0 |
|
08/11/2023 |
4
| Azelby Robert (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 28,200 options to buy
@ $21.6, valued at
$609.1k
Disposed/sold 7,000 restricted stock units
@ $0 |
|
08/11/2023 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed/sold 3,300 shares
@ $0 Disposed/sold 5,161,888 shares
@ $0 Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2023 |
4
| Greenman William Mariner (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Sold 1,155 shares
@ $23.3, valued at
$26.9k
Exercised 3,300 restricted stock units
@ $0 |
|
05/31/2023 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Exercised 3,300 restricted stock units
@ $0 |
|
05/31/2023 |
4
| Haghighat Ross (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Exercised 3,300 restricted stock units
@ $0 |
|
05/31/2023 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Exercised 3,300 restricted stock units
@ $0 |
|
05/31/2023 |
4
| Jerel Davis (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Exercised 3,300 restricted stock units
@ $0 |
|
05/31/2023 |
4
| Thomas Dolca (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Exercised 3,300 restricted stock units
@ $0 |
|
04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/05/2023 |
4
| King Andrew James (Chief Scientific Officer) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Sold 5,000 shares
@ $23.3435, valued at
$116.7k
Exercised 2,500 options to buy
@ $0.35, valued at
$875 |
|
04/04/2023 |
4
| Krishnan Mahesh (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Sold 924 shares
@ $23.01, valued at
$21.3k
Exercised 2,199 restricted stock units
@ $0 |
|
03/02/2023 |
4
| Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Granted 160,000 options to buy
@ $21.82, valued at
$3.5M
Granted 40,000 options to buy
@ $0 |
|
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2023 |
4
| DOBMEIER ERIC (President, CEO) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Sold 25,000 shares
@ $24.5445, valued at
$613.6k
Sold 7,688 shares
@ $24.6822, valued at
$189.8k
Exercised 25,000 options to buy
@ $0.42, valued at
$10.5k
Granted 255,150 options to buy
@ $25.27, valued at
$6.4M
Granted 64,050 restricted stock units
@ $0 Exercised 24,999 restricted stock units
@ $0 |
|
01/04/2023 |
4
| King Andrew James (Chief Scientific Officer) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Sold 10,000 shares
@ $25.8183, valued at
$258.2k
Exercised 7,500 options to buy
@ $0.35, valued at
$2.6k
|
|
12/27/2022 |
4
| Jerel Davis (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns:
| Disposed of 364,587 shares
@ $0 Acquired 3,600 shares
@ $0 Disposed of 108,715 shares
@ $0 Acquired 5,865 shares
@ $0 Disposed of 9,465 shares
@ $0 Acquired 1,646 shares
@ $0 |
|
12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|